Shanghai Kehua Bio-Engineering Co Ltd (002022) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Kehua Bio-Engineering Co Ltd (002022) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.25 Million ≈ $4.13 Million USD) by net assets (CN¥3.70 Billion ≈ $541.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Kehua Bio-Engineering Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Shanghai Kehua Bio-Engineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Shanghai Kehua Bio-Engineering Co Ltd carry for a breakdown of total debt and financial obligations.
Shanghai Kehua Bio-Engineering Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Kehua Bio-Engineering Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fujian SBS Zipper Science Tech
SHE:002098
|
0.059x |
|
Huchems
KO:069260
|
0.030x |
|
Hampidjan hf
IC:HAMP
|
0.016x |
|
I-Mab
NASDAQ:IMAB
|
0.007x |
|
Banco Santander Brasil SA
BA:BSBR
|
-0.157x |
|
Tianyang Hot Mel
SHG:603330
|
0.078x |
|
Funeng Oriental Equipment Technology Co Ltd
SHE:300173
|
0.007x |
|
Jiangling Motors Corp Ltd
SHE:200550
|
0.212x |
Annual Cash Flow Conversion Efficiency for Shanghai Kehua Bio-Engineering Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Kehua Bio-Engineering Co Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Shanghai Kehua Bio-Engineering Co Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.98 Billion ≈ $582.75 Million |
CN¥-50.12 Million ≈ $-7.33 Million |
-0.013x | +86.79% |
| 2023-12-31 | CN¥4.98 Billion ≈ $729.35 Million |
CN¥-474.89 Million ≈ $-69.49 Million |
-0.095x | -125.89% |
| 2022-12-31 | CN¥5.85 Billion ≈ $856.33 Million |
CN¥2.15 Billion ≈ $315.14 Million |
0.368x | +74.98% |
| 2021-12-31 | CN¥5.13 Billion ≈ $750.87 Million |
CN¥1.08 Billion ≈ $157.92 Million |
0.210x | -40.02% |
| 2020-12-31 | CN¥3.90 Billion ≈ $570.55 Million |
CN¥1.37 Billion ≈ $200.06 Million |
0.351x | +279.08% |
| 2019-12-31 | CN¥2.69 Billion ≈ $393.70 Million |
CN¥248.87 Million ≈ $36.42 Million |
0.093x | +77.28% |
| 2018-12-31 | CN¥2.43 Billion ≈ $355.59 Million |
CN¥126.79 Million ≈ $18.55 Million |
0.052x | -17.01% |
| 2017-12-31 | CN¥2.08 Billion ≈ $304.24 Million |
CN¥130.71 Million ≈ $19.13 Million |
0.063x | -57.51% |
| 2016-12-31 | CN¥1.90 Billion ≈ $278.14 Million |
CN¥281.25 Million ≈ $41.16 Million |
0.148x | +13.84% |
| 2015-12-31 | CN¥1.73 Billion ≈ $252.51 Million |
CN¥224.30 Million ≈ $32.82 Million |
0.130x | -34.00% |
| 2014-12-31 | CN¥1.27 Billion ≈ $185.50 Million |
CN¥249.64 Million ≈ $36.53 Million |
0.197x | -4.92% |
| 2013-12-31 | CN¥1.21 Billion ≈ $176.79 Million |
CN¥250.22 Million ≈ $36.62 Million |
0.207x | +5.27% |
| 2012-12-31 | CN¥1.09 Billion ≈ $158.98 Million |
CN¥213.74 Million ≈ $31.28 Million |
0.197x | -8.18% |
| 2011-12-31 | CN¥1.03 Billion ≈ $150.12 Million |
CN¥219.80 Million ≈ $32.16 Million |
0.214x | -17.48% |
| 2010-12-31 | CN¥931.34 Million ≈ $136.28 Million |
CN¥241.83 Million ≈ $35.39 Million |
0.260x | -5.36% |
| 2009-12-31 | CN¥792.82 Million ≈ $116.01 Million |
CN¥217.51 Million ≈ $31.83 Million |
0.274x | +28.29% |
| 2008-12-31 | CN¥643.75 Million ≈ $94.20 Million |
CN¥137.66 Million ≈ $20.14 Million |
0.214x | -7.88% |
| 2007-12-31 | CN¥486.48 Million ≈ $71.19 Million |
CN¥112.93 Million ≈ $16.53 Million |
0.232x | +5.95% |
| 2006-12-31 | CN¥398.02 Million ≈ $58.24 Million |
CN¥87.21 Million ≈ $12.76 Million |
0.219x | +12.77% |
| 2005-12-31 | CN¥380.71 Million ≈ $55.71 Million |
CN¥73.97 Million ≈ $10.82 Million |
0.194x | +52.22% |
| 2004-12-31 | CN¥381.82 Million ≈ $55.87 Million |
CN¥48.74 Million ≈ $7.13 Million |
0.128x | -71.25% |
| 2003-12-31 | CN¥158.92 Million ≈ $23.26 Million |
CN¥70.57 Million ≈ $10.33 Million |
0.444x | +56.53% |
| 2002-12-31 | CN¥146.21 Million ≈ $21.39 Million |
CN¥41.48 Million ≈ $6.07 Million |
0.284x | -- |
About Shanghai Kehua Bio-Engineering Co Ltd
Shanghai Kehua Bio-Engineering Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of in vitro diagnostic reagents and medical testing equipment and services in China and internationally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated co… Read more